Skip to content

Application of Preoperative Axillary Lymph Node Marking with Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy

Application of Preoperative Axillary Lymph Node Marking with Nano-Carbon in?Breast Cancer Patients Before Neoadjuvant Chemotherapy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031346
Enrollment
Unknown
Registered
2020-03-28
Start date
2020-03-20
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Case series:Tattooing of biopsied node

Sponsors

Union Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Female; 2. Aged >=18 years; 3. With invasive breast cancer; 4. Patients to be treated with neoadjuvant chemotherapy; 5. Patients scheduled to undergo routine fine needle aspiration (FNA) or core biopsy of abnormal axillary lymph node; 6. Patients with operable breast cancer; 7. Heart, lung, liver and kidney function well, suitable for patients undergoing surgery; 8. Informed consent patients.

Exclusion criteria

Exclusion criteria: 1. Patients who do not plan or are unable to operate; 2. Patients with distant metastasis were excluded; 3. Patients without invasive cancer components in DCIS alone; 4. Patients who are unable to cooperate with the doctor's recommended surgical treatment (breast conserving surgery or radical surgery) due to personal or family factors; 5. Patients with serious cardiopulmonary diseases, uncontrolled infectious diseases and other non tumor related diseases who can not tolerate comprehensive treatment such as surgery and chemotherapy; 6. Patients with mental illness or other reasons unable to sign informed consent; 7. Patients with poor medical compliance who cannot complete the trial treatment process and follow-up according to the standard according to the researcher's opinion.

Design outcomes

Primary

MeasureTime frame
Identification rate of tattooed node;

Secondary

MeasureTime frame
Concordance of tattooed node and sentinel lymph node;

Countries

China

Contacts

Public ContactChuan Wang

Union Hospital Affiliated to Fujian Medical University

chuanwang1968@outlook.com+86 13365910252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026